INOVIO PHARMACEUTICALS, INC.·4

Jul 1, 4:08 PM ET

Sumner Michael John 4

4 · INOVIO PHARMACEUTICALS, INC. · Filed Jul 1, 2025

Insider Transaction Report

Form 4
Period: 2025-06-30
Sumner Michael John
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2025-06-302,9160 total
    Common Stock (2,916 underlying)
  • Exercise/Conversion

    Common Stock

    2025-06-30+2,91617,850 total
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 8,749 restricted stock units was as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares vested on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

Documents

1 file
  • 4
    wk-form4_1751400477.xmlPrimary

    FORM 4